Statement in response to Alzheimer’s Research Institute study into the use of neuroleptic drugs to treat symptoms of dementia

30 March 2007

 

Professor Mayur Lakhani, Chair of the Royal College of General Practitioners (RCGP), says:

 

“As a practising GP, I often see the effects of aggressive and agitative behaviours in patients with dementia. This can be distressing for both patients and their carers.

 

“We would like to reassure patients, relatives and carers that neuroleptic drugs are not routinely prescribed to patients with dementia, and are used only as a last resort when patients suffer from severe episodes.

 

“The decision to prescribe neuroleptics to Alzheimer’s patients is not one that is taken lightly, and often, they are prescribed on the advice of specialists or as part of a shared care protocol.

 

“We agree that there needs to be vigilance about the prescribing of these drugs for dementia. The study also appears to indicate a need for research into alternative drugs, and for more consideration to be given to other ways of coping with challenging behaviour, such as psychological therapies.

 

“It is important that this research is now fully published and peer reviewed so that its findings can be fully considered.”

 

Ends

 

For further information contact Lorna Fletcher on 0207 344 3136 or email press@rcgp.org.uk

If you encounter a problem with this page please email the web team
© Royal College of General Practitioners 2008
Registered Charity Number - 223106